Literature DB >> 22633206

Outcome and resource utilization of infants born with hypoplastic left heart syndrome in the Intermountain West.

Shaji C Menon1, Heather T Keenan, Hsin-Yi Cindy Weng, Linda M Lambert, Philip T Burch, Reggi Edwards, Alison Spackman, Kent E Korgenski, Lloyd Y Tani.   

Abstract

The objective of the present study was to characterize the outcomes and resource utilization of all infants born with hypoplastic left heart syndrome (HLHS) in the Intermountain West. This was a retrospective cohort study of all infants born with HLHS in the Intermountain West from January 1995 and January 2010. The cohort was divided into 3 eras: era 1, 1995 to 1999; era 2, 2000 to 2004; and era 3, 2005 to 2010. Cox proportional hazards regression analysis was performed to assess mortality. The lifetime hospitalization days and charges were also determined. Of the 245 infants identified, 65% were male infants and 172 (70%) underwent Stage 1 palliation. The transplant-free survival rate for the entire cohort was 33% at 14 years. The 1-year transplant-free survival rate for the surgical cohort was 60% in era 3. The infants whose initial presentation included shock, restrictive or intact atrial septum, chromosomal defects, or multiorgan dysfunction had an increased risk of death. A recent era of birth, greater birthweight, and older gestational age were associated with improved survival. The factors associated with mortality after stage 1 included surgical procedure type (Blalock-Taussig vs Sano shunt, hazard ratio 2.1), requirement for postoperative extracorporeal membrane oxygenation (hazard ratio 4.2), postoperative renal dysfunction (hazard ratio 3.0), anomalous pulmonary venous return (hazard ratio 2.9), and moderate or greater tricuspid valve regurgitation at any point (hazard ratio 2.0). For patients who had undergone stage 1, 2, or 3 palliation, the median cumulative lifetime hospitalization was 32, 48, and 65 days, and the median cumulative lifetime charges for hospitalization were $201,812, $253,183, and $296,213, respectively. In conclusion, although hospital-based studies of HLHS have shown significantly improved survival after surgical palliation, population-based studies have shown that HLHS continues to have a high mortality and high resource utilization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633206     DOI: 10.1016/j.amjcard.2012.04.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Overall Hospital Cost Estimates in Children with Congenital Heart Disease: Analysis of the 2012 Kid's Inpatient Database.

Authors:  David Faraoni; Viviane G Nasr; James A DiNardo
Journal:  Pediatr Cardiol       Date:  2015-07-17       Impact factor: 1.655

2.  Survival of Children With Hypoplastic Left Heart Syndrome.

Authors:  Csaba Siffel; Tiffany Riehle-Colarusso; Matthew E Oster; Adolfo Correa
Journal:  Pediatrics       Date:  2015-09-21       Impact factor: 7.124

3.  Alteration of cardiolipin biosynthesis and remodeling in single right ventricle congenital heart disease.

Authors:  Anastacia M Garcia; Jessica C McPhaul; Genevieve C Sparagna; Danielle A Jeffrey; Raleigh Jonscher; Sonali S Patel; Carmen C Sucharov; Brian L Stauffer; Shelley D Miyamoto; Kathryn C Chatfield
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-14       Impact factor: 4.733

4.  Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-β signaling.

Authors:  Indroneal Banerjee; Katrina Carrion; Ricardo Serrano; Jeffrey Dyo; Roman Sasik; Sean Lund; Erik Willems; Seema Aceves; Rudolph Meili; Mark Mercola; Ju Chen; Alexander Zambon; Gary Hardiman; Taylor A Doherty; Stephan Lange; Juan C del Álamo; Vishal Nigam
Journal:  J Mol Cell Cardiol       Date:  2014-11-13       Impact factor: 5.000

5.  Copy Number Variants of Undetermined Significance Are Not Associated with Worse Clinical Outcomes in Hypoplastic Left Heart Syndrome.

Authors:  Andrew L Dailey-Schwartz; Hanna J Tadros; Mahshid Sababi Azamian; Seema R Lalani; Shaine A Morris; Hugh D Allen; Jeffrey J Kim; Andrew P Landstrom
Journal:  J Pediatr       Date:  2018-08-29       Impact factor: 4.406

6.  Myocardial Response to Milrinone in Single Right Ventricle Heart Disease.

Authors:  Stephanie J Nakano; Penny Nelson; Carmen C Sucharov; Shelley D Miyamoto
Journal:  J Pediatr       Date:  2016-05-12       Impact factor: 4.406

7.  Trends in Discharge Prescription of Digoxin After Norwood Operation: An Analysis of Data from the Pediatric Health Information System (PHIS) Database.

Authors:  Michael L O'Byrne; Lihai Song; Jing Huang; David J Goldberg; Monique M Gardner; Chitra Ravishankar; Jonathan J Rome; Andrew C Glatz
Journal:  Pediatr Cardiol       Date:  2021-02-02       Impact factor: 1.655

8.  Mortality-related resource utilization in the inpatient care of hypoplastic left heart syndrome.

Authors:  David A Danford; Quentin Karels; Aparna Kulkarni; Aysha Hussain; Yunbin Xiao; Shelby Kutty
Journal:  Orphanet J Rare Dis       Date:  2015-10-22       Impact factor: 4.123

Review 9.  Resource and cost considerations in treating hypoplastic left heart syndrome.

Authors:  Miguel Urencio; Chris Greenleaf; Jorge D Salazar; Ali Dodge-Khatami
Journal:  Pediatric Health Med Ther       Date:  2016-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.